JP2002540077A5 - - Google Patents

Download PDF

Info

Publication number
JP2002540077A5
JP2002540077A5 JP2000606266A JP2000606266A JP2002540077A5 JP 2002540077 A5 JP2002540077 A5 JP 2002540077A5 JP 2000606266 A JP2000606266 A JP 2000606266A JP 2000606266 A JP2000606266 A JP 2000606266A JP 2002540077 A5 JP2002540077 A5 JP 2002540077A5
Authority
JP
Japan
Prior art keywords
chitosan
polycationic carbohydrate
polycationic
composition according
carbohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000606266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002540077A (ja
JP5124066B2 (ja
Filing date
Publication date
Priority claimed from GBGB9906694.6A external-priority patent/GB9906694D0/en
Priority claimed from GBGB9906696.1A external-priority patent/GB9906696D0/en
Application filed filed Critical
Priority claimed from PCT/GB2000/001118 external-priority patent/WO2000056362A2/en
Publication of JP2002540077A publication Critical patent/JP2002540077A/ja
Publication of JP2002540077A5 publication Critical patent/JP2002540077A5/ja
Application granted granted Critical
Publication of JP5124066B2 publication Critical patent/JP5124066B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000606266A 1999-03-24 2000-03-23 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用 Expired - Fee Related JP5124066B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9906694.6 1999-03-24
GBGB9906694.6A GB9906694D0 (en) 1999-03-24 1999-03-24 Vaccine composition
GBGB9906696.1A GB9906696D0 (en) 1999-03-24 1999-03-24 Vaccine composition
GB9906696.1 1999-03-24
PCT/GB2000/001118 WO2000056362A2 (en) 1999-03-24 2000-03-23 Polycationic carbohydrates as immunostimulants in vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011204971A Division JP2012031186A (ja) 1999-03-24 2011-09-20 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用

Publications (3)

Publication Number Publication Date
JP2002540077A JP2002540077A (ja) 2002-11-26
JP2002540077A5 true JP2002540077A5 (cg-RX-API-DMAC7.html) 2007-05-24
JP5124066B2 JP5124066B2 (ja) 2013-01-23

Family

ID=26315329

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000606266A Expired - Fee Related JP5124066B2 (ja) 1999-03-24 2000-03-23 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用
JP2000606265A Withdrawn JP2002540076A (ja) 1999-03-24 2000-03-23 ワクチン組成物
JP2011204971A Pending JP2012031186A (ja) 1999-03-24 2011-09-20 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2000606265A Withdrawn JP2002540076A (ja) 1999-03-24 2000-03-23 ワクチン組成物
JP2011204971A Pending JP2012031186A (ja) 1999-03-24 2011-09-20 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用

Country Status (11)

Country Link
US (1) US20080057083A1 (cg-RX-API-DMAC7.html)
EP (2) EP1163002B1 (cg-RX-API-DMAC7.html)
JP (3) JP5124066B2 (cg-RX-API-DMAC7.html)
AT (1) ATE403436T1 (cg-RX-API-DMAC7.html)
AU (2) AU755502C (cg-RX-API-DMAC7.html)
CA (2) CA2366908A1 (cg-RX-API-DMAC7.html)
DE (1) DE60039754D1 (cg-RX-API-DMAC7.html)
DK (1) DK1163002T3 (cg-RX-API-DMAC7.html)
ES (1) ES2311451T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ514323A (cg-RX-API-DMAC7.html)
WO (2) WO2000056362A2 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399695A1 (en) * 2000-03-22 2001-09-27 The Secretary Of State For Defence Pharmaceutical composition for administration to mucosal surfaces
EP1315672A4 (en) 2000-06-22 2006-04-26 Rxkinetix Inc ADMINISTRATIVE COMPOSITION COMPOSITION AND METHOD FOR THE ADMINISTRATION OF ANTIGENES AND OTHER ACTIVE SUBSTANCES
AU2001273034A1 (en) 2000-06-26 2002-01-08 Rxkinetix, Inc. Composition for delivery of hematopoietic growth factor
JP2005514326A (ja) * 2001-07-10 2005-05-19 コリクサ コーポレイション ミクロスフェア中に封入されたタンパク質およびアジュバントを送達するための組成物および方法
ES2295391T3 (es) 2001-08-16 2008-04-16 Cmp Therapeutics Limited Microparticulas de quitina y sus usos medicos.
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
PT1432402E (pt) * 2001-10-03 2007-02-28 Celator Pharmaceuticals Inc Composições para administração de combinações de fármacos
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition
JP2006516609A (ja) * 2003-01-30 2006-07-06 カイロン ソチエタ ア レスポンサビリタ リミタータ 粘膜髄膜炎菌性ワクチン
CA2514667C (en) * 2003-01-30 2013-01-08 Chiron Corporation Adjuvanted influenza vaccine
ES2596553T3 (es) 2003-06-02 2017-01-10 Glaxosmithkline Biologicals Sa Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido
JP4669665B2 (ja) * 2004-04-12 2011-04-13 正彦 阿部 細胞毒性のないポリカチオン修飾リポソームおよびその製造方法
GB0519871D0 (en) 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
US8431160B2 (en) * 2006-02-24 2013-04-30 Novartis Ag Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
WO2008041703A1 (en) * 2006-10-02 2008-04-10 Osaka University Adjuvant for influenza vaccine and influenza vaccine
JP5297009B2 (ja) * 2007-07-24 2013-09-25 大日精化工業株式会社 免疫アジュバント水溶液
MY148321A (en) * 2007-10-02 2013-03-29 Malaysian Palm Oil Board Mpob Vitamin e supplementation to tetanus toxoid
GB0721937D0 (en) 2007-11-08 2007-12-19 Secr Defence Rodenticide
WO2010017330A1 (en) * 2008-08-06 2010-02-11 Novartis Ag Microparticles for use in immunogenic compositions
GB0900455D0 (en) 2009-01-13 2009-02-11 Secr Defence Vaccine
ES2728653T3 (es) * 2011-05-18 2019-10-28 Matrivax Inc Composiciones vacunales con una matriz proteica que incluye policationes
WO2012164480A1 (en) * 2011-05-30 2012-12-06 National Institute Of Immunology A vaccine composition capable of inducing memory antibody response from single point immunization
CN107200788B (zh) * 2017-05-11 2020-04-14 暨南大学 一种季鏻化壳聚糖及其作为疫苗免疫佐剂的应用
CN107899021A (zh) * 2017-11-06 2018-04-13 扬州大学 一种表面修饰s‑层蛋白的壳聚糖微球、制备及应用
KR102384808B1 (ko) * 2018-12-20 2022-04-08 주식회사 스킨메드 키토산으로 코팅된 나노 캡슐 및 이의 용도
EP3960203A1 (en) 2020-08-25 2022-03-02 Université de Liège Complexes for the delivery of proteinaceous agents

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
GB1290141A (cg-RX-API-DMAC7.html) * 1968-05-31 1972-09-20
FR2306684A1 (fr) * 1975-04-11 1976-11-05 Crinex Lab Nouvelle composition a action immunostimulante
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
ES2052685T3 (es) * 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
ATE115862T1 (de) * 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
US5562910A (en) * 1989-09-25 1996-10-08 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
DE4004430A1 (de) * 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
CN1120310A (zh) * 1993-03-11 1996-04-10 塞科雷泰克公司 在粘膜表面转运免疫原的聚合粘膜粘合剂
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6913767B1 (en) * 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
GB9419979D0 (en) * 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
DK0815235T3 (da) * 1995-03-13 2003-04-22 Secr Defence Vacciner mod pest
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
DE19603649A1 (de) * 1996-02-01 1997-08-07 Werner Lubitz Rekombinante Expression von S-Layer-Proteinen
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB9810126D0 (cg-RX-API-DMAC7.html) * 1998-05-13 1998-07-08 Glaxo Group Ltd
IL142896A0 (en) * 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US20030171258A1 (en) * 1999-03-24 2003-09-11 Alpar Hazire Oya Particle based vaccine composition
US20020103165A1 (en) * 2000-02-29 2002-08-01 Alliance Pharmaceutical Corp., Engineered spray-dried lipid-based microparticles for cellular targeting
CA2399695A1 (en) * 2000-03-22 2001-09-27 The Secretary Of State For Defence Pharmaceutical composition for administration to mucosal surfaces
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition

Similar Documents

Publication Publication Date Title
CA2366216A1 (en) Polycationic carbohydrates as immunostimulants in vaccines
KR100201352B1 (ko) 단일주사 백신 제형
Vila et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Esparza et al. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
JP2009080118A5 (cg-RX-API-DMAC7.html)
CA2731995C (en) Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
EP1107782B1 (en) Oral vaccine compositions
WO2001017556A1 (fr) Préparations vaccinales administrables par les muqueuses
Florindo et al. New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model
JP2002539237A (ja) 粒子を基本としたワクチン組成物
US20210402006A1 (en) Nanoparticles and uses thereof
US20230218752A1 (en) Polymeric nanoparticles as vaccine adjuvants
WO2002043756A3 (es) Método de obtención de agregados antigénicos y su uso en formulaciones
CN118576551A (zh) 吸入用脂质纳米凝胶的制备与应用